跳至主要内容
临床试验/IRCT20221129056657N2
IRCT20221129056657N2招募中3 期

The effectiveness of oral compounds derived from Organosulfur as the treatment in pediatrics with pneumonia.

Hossein Niktale - the inventor of medicine0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 years 至 16 years(—)
性别
All

入选标准

  • Patient age 3 to 16 years
  • The patient does not need a ventilator
  • A patient with pneumonia and hospitalized in the special care, infectious and lung department

排除标准

  • History of allergy to allicin-L-cysteine
  • History of allergy to garlic and onion
  • Patients with a history of hypotension or gastrointestinal bleeding
  • Low blood pressure of the patient at the beginning of the study (below 120/80)
  • Immune compromised patients - under chemotherapy, organ and bone marrow transplantation, and patients with autoimmune diseases
  • The patient's inability to swallow oral medication that is not embedded in the NGtube or other delivery method.

研究者

发起方
Hossein Niktale - the inventor of medicine

相似试验